SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 278 filers reported holding SAGE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $105,000 | +1650.0% | 1,403 | +601.5% | 0.00% | – |
| Q1 2020 | $6,000 | -93.9% | 200 | -85.3% | 0.00% | -100.0% |
| Q4 2019 | $98,000 | -41.0% | 1,363 | +17.2% | 0.00% | -50.0% |
| Q3 2019 | $166,000 | -18.6% | 1,163 | +4.4% | 0.01% | -33.3% |
| Q2 2019 | $204,000 | -81.1% | 1,114 | -83.6% | 0.01% | -81.6% |
| Q1 2019 | $1,079,000 | +639.0% | 6,787 | +346.8% | 0.05% | +716.7% |
| Q4 2018 | $146,000 | -33.3% | 1,519 | -2.0% | 0.01% | -50.0% |
| Q3 2018 | $219,000 | -9.9% | 1,550 | 0.0% | 0.01% | -40.0% |
| Q2 2018 | $243,000 | -2.8% | 1,550 | 0.0% | 0.02% | -39.4% |
| Q1 2018 | $250,000 | – | 1,550 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |